Clinical case of encephalitis with antibodies to NMDA receptors
https://doi.org/10.22627/2072-8107-2019-18-4-67-69
Abstract
Anti-NMDA receptor encephalitis is an autoimmune disease of the central nervous system caused by autoantibodies to the NR1 and NR2 subunits of the glutamate NMDA receptor, with the possibility of both death and rapid remission. The binding of these antibodies blocks receptors and causes slowly developing psychiatric disorders, motor disorders and seizures.
Presented clinical observation in a 9-year-old patient. The disease debuted with prodromal flu-like symptoms, fever, headache and general weakness, after which neuropsychiatric symptoms, impaired memory and speech developed, further progression of the disease, convulsive status, and coma with a fatal outcome were noted. The final diagnosis of autoimmune encephalitis was made after identification of antibodies to the N-methyl-D-aspartate (NMDA) receptor in the blood.
About the Authors
L. U. UlukhanovaRussian Federation
Lala Ulukhanovа, MD
Makhachkala
N. S. Karnayeva
Russian Federation
Makhachkala
M. M. Yaraliev
Russian Federation
A. G. Gadzhimirzaevа
Russian Federation
Makhachkala
S. G. Agaevа
Russian Federation
Makhachkala
References
1. Iizuka T., Sakai F., Ide T., Monzen T., Yoshii S., Iigaya M., Suzuki K., Lynch D.R., Suzuki N., Hata T., Dalmau J. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. February 2008; 70(7):504—11. DOI:10.1212/01.wnl.0000278388.90370.c3. PMID 17898324.
2. Dalmau J., Tüzün E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.A., Rosenfeld M.R., Lynch D.R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. January 2007. 61(1):25—36. DOI:10.1002/ana.21050. PMID 17262855.
3. Florance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., Campen C.J., Moss H., Peter N., Gleichman A.J., Glaser C.A., Lynch D.R., Rosenfeld M.R., Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol. July 2009. 66(1):11—8. DOI:10.1002/ana.21756. PMID 19670433.
4. Chapman M.R., Vause H.E. Anti-NMDA Receptor Encephalitis: Diagnosis, Psychiatric Presentation, and Treatment. J Psychiat. 2011; 168(3):245—251.
5. Florance N.R. Anti-N-Methyl-D-Aspartate ReceptorEncephalitis in Children and Adolescents. Ann Neurol. 2010; http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826225
6. Titulaer M.J. Treatment and prognostic factors for longterm outcome in patients with anti-N-Methyl-D-Aspartate receptor encephalitis: a cohort study. Lancet Neurol. 2013; 12:157—165.
7. Xu C.L. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up BMC. Neurology. 2011; 11:149.
8. Sorokina M.N., Skripchenko N.V. Viral encephalitis and meningitis in children. M.: Meditsina, 2004:416. (In Russ.)
9. Luca N. Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Newly Recognized Inflammatory Brain Disease in Children. Arthritis Rheum. 2011; 63: 2516—2522.
10. Sansing L.H., Tüzün E., Ko M.W., Baccon J., Lynch D.R., Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies». Nat Clin Pract Neurol. May 2007. 3(5):291—6. DOI:10.1038/ncpneuro0493. PMID 17479076.
Review
For citations:
Ulukhanova L.U., Karnayeva N.S., Yaraliev M.M., Gadzhimirzaevа A.G., Agaevа S.G. Clinical case of encephalitis with antibodies to NMDA receptors. CHILDREN INFECTIONS. 2019;18(4):67-69. (In Russ.) https://doi.org/10.22627/2072-8107-2019-18-4-67-69